Who We Are
The Therapeutics Initiative (TI) was established in 1994 by the Department of Pharmacology and Therapeutics in cooperation with the Department of Family Practice at The University of British Columbia with its mission to provide physicians and pharmacists with up-to-date, evidence-based, practical information on prescription drug therapy.
To reduce bias as much as possible the TI is an independent organization, separate from government, pharmaceutical industry and other vested interest groups. We strongly believe in the need for independent assessments of evidence on drug therapy to balance the drug industry sponsored information sources.
Our organization consists of two Co-Managing Directors (Dr. Ken Bassett and Dr. Colin Dormuth), an Oversight Committee, the Steering Committee and Working Groups.
What We Do
Over the years the TI has substantially enhanced its ability to assess the clinical evidence presented in published articles, meta-analyses by the Cochrane Collaboration and scientific material presented by the pharmaceutical industry.
In pace with the extensive assessment of clinical evidence, the TI has developed effective ways of knowledge translation and dissemination of this evidence to all active players involved in drug therapy: physicians, pharmacists, nurses and policy-makers (Ministry of Health) and is committed to analyzing its own impact.
Read our latest Therapeutics Letters and Our Evidence Reviews.
How We Are Funded
The Therapeutics Initiative is funded by the British Columbia Ministry of Health. Our website does not host any form of advertisement.
For more information on donor requirements, please read our Donate page.
Conflict of Interest
The Therapeutics Initiative has strict conflict of interest guidelines to ensure we meet the highest ethical standards and maintain our integrity. Transparent disclosure is essential to achieving these objectives. Participants in all aspects of our work ensure that they remain free from conflicts of interest. If a potential conflict arises, we strive to identify and resolve it. We welcome scientific or other comments to our website, but expect commentators who wish their remarks to be posted to meet the same standards by completing and submitting a standard disclosure of potential conflicts of interest form.
